Oryon Cell Therapies News and Activities

Acquisition, funding and merger involving Oryon Cell Therapies.

• Oryon Cell Therapies has just announced a $42 Million fundraising (posted on March 25 2026).

View the org chart displaying its 6 main executives

Most searched biographies at Oryon Cell Therapies

• Ron Cohen, Chief Executive Officer
• Adam Knight, Director
• Ole Isacson, Director

Popular executive movements at Oryon Cell Therapies

• Burkhard Blank has joined the company as Chief Medical Officer  (posted on April 16 2026).
• Nikola Kojic, who was Chief Executive Officer, is promoted to Chief Innovation Officer  (posted on March 25 2026).
• Emmett Cunningham has joined the company as Chairman of the Board  (posted on March 25 2026).

Click here to view some more movements at Oryon Cell Therapies

Create your alert
to follow the executive moves at Oryon Cell Therapies.

Oryon Cell Therapies has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Oryon Cell Therapies

• News - Oryon Cell Therapies

Social media about Oryon Cell Therapies

• Oryon Cell Therapies on Wikipedia, Google News & Yahoo Finance
• Oryon Cell Therapies on LinkedIn, X (Twitter) & YouTube